12th International Congress of Radiation Research

描述(申请人提供)：1895年朗托根发现了X射线，1896年贝克勒尔发现了放射性，随后对电离辐射的损害和治疗作用(包括遗传效应，穆勒后来因此获得诺贝尔奖)进行了早期评估。由此产生了辐射研究，这是一个涵盖物理、化学、生物和医学的多学科领域，所有这些都用于造福人类。辐射研究学会于1952年在美国成立，不久后在英国、欧洲几个国家(荷兰、瑞典、波兰、德国、意大利和法国)、日本和以色列成立了学会。这些学会现在组成了国际辐射研究协会(IARR)，这是国际生物科学联合会的一个组成部分。第一届国际辐射研究大会于1958年在佛蒙特州伯灵顿举行，从那时起，国际辐射研究协会每隔四年在英国、意大利、法国、日本、荷兰、美国、苏格兰、德国和爱尔兰举办一次国际辐射研究大会。第十二届大会将于2003年在澳大利亚布里斯班举行。该主题领域的多学科性质使这些国际会议特别有价值。对一般环境危害、癌症研究和癌症治疗感兴趣的物理学家、化学家、生物学家和医生将开会讨论他们的进展。鉴于美国和加拿大科学家在这一领域的领导作用，来自北美的与会者人数较多是合适的。确保活跃在该领域的青年科学家的充分参与也特别重要。为此目的，请拨资金支持辐射研究学会代表生物、化学、医学和物理学科的33名年轻成员的旅费。遴选标准为：参加大会、辐射研究出版物、年龄和专业地位(样本评估表见附录)。将作出特别努力，确保妇女和少数群体有良好的代表性。

DESCRIPTION (provided by applicant): The discovery of X-rays by Rontogen in 1895 and radioactivity by Becquerel in 1896 were followed by an early appreciation of both the damaging and therapeutic effect of ionizing radiation (including genetic effects, for which Muller later received the Nobel Prize). From this emerged radiation research, a multidisciplinary field embracing physics, chemistry, biology, and medicine, all of which are used to the benefit of man. The Radiation Research Society was formed in the USA in 1952, and was followed soon after by the formation of societies in Great Britain, several countries in Europe (the Netherlands, Sweden, Poland, Germany, Italy, and France), Japan, and Israel. The societies now form the International Association for Radiation Research (IARR), a component of the International Union of the Biological Sciences. The first International Congress of Radiation Research was held in Burlington, Vermont, in 1958, and since then, at four-year intervals, International Congresses sponsored by the IARR have been held in England, Italy, France, Japan, the Netherlands, the United States, Scotland, Germany and Ireland. The 12th Congress will be held in Brisbane, Australia in 2003. The multidisciplinary nature of the subject area renders these international meetings especially valuable. Physicists, chemists, biologists, and physicians interested in environmental hazards in general, cancer research, and cancer therapy in general, will meet to discuss their progress. It is appropriate that a substantial contingent of attendees be from North America, in view of the leading role of American and Canadian scientists in this field. It is also particularly important to ensure adequate participation of young scientists active in the field. For this purpose, funds are requested to support the travel of 33 young members of the Radiation Research Society representing the disciplines of Biology, Chemistry, Medicine, and Physics. Selection criteria are: Congress participation, publications in radiation research, age, and professional standing (sample evaluation form included in Appendix). Special effort will be made to ensure good representation of women and minorities.